🇺🇸 FDA
Patent

US 6706873

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6706873 (Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P1/16